Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Synaptogyrin 3 ELISA Kit (AC3090)
Cat.#: ASET-1679
Specifications
Description Human Synaptogyrin 3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Synaptogyrin 3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.023 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2240 Human RKIP ELISA Kit (AC3651) Quantitative inquiry ASET-2353 Human Insulin ELISA Kit (AC3764) Quantitative inquiry ASET-1996 Human SCAMP1 ELISA Kit (AC3407) Quantitative inquiry ASET-1571 Human VCAM1 ELISA Kit (AC2982) Quantitative inquiry ASET-1980 Human Serine Racemase ELISA Kit (AC3391) Quantitative inquiry ASET-2424 Human Noelin ELISA Kit (AC3835) Quantitative inquiry ASET-1689 Human GABA A Receptor alpha 1 ELISA Kit (AC3100) Quantitative inquiry ASET-2365 Bovine IL-6 ELISA Kit (AC3776) Quantitative inquiry ASET-2481 Mouse BDNF ELISA Kit (AC3892) Quantitative inquiry ASET-2176 Human Bim ELISA Kit (AC3587) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket